U.S. Renal Care nelle notizie
Servizi di cura delle malattie renali
Tamtam ha trovato 20 articoli recenti su U.S. Renal Care.
- U.S. Renal Care & Satellite Healthcare Honor 25 Nurses with National DAISY Award During Nephrology Nurses Week
- Waystar reports 80 percent time savings for US Renal Care in recoupment management
- PHTI report finds limited impact from virtual kidney care solutions, prompting industry pushback
- US Special Situations: US Renal Care looks to unwind asset strip move from 2023 LME in latest refi plan – Report
- US Renal Care Number of Employees 2026 | Employee Count & Headcount Data
- Kidney care provider expands access to new therapy
- US Special Situations: US Renal Care looks to unwind asset strip move from 2023 LME in latest refi plan – Report
- U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
- U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
- U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
- U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
- U.S. Renal Care Drives Innovation in Dialysis with Increased Availability of Medium Cut-Off Dialyzers to Support Expanded Hemodialysis
- Bain’s US Renal Care Seeks to Undo Asset Strip in Rare Debt Move
- U.S. Renal Care Premieres Short Film About One Runner's Race for Kidney Disease Awareness
- U.S. Renal Care and Akebia Therapeutics, Inc. Announce Interim Analysis of VOICE Trial Demonstrates Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo Versus ESA
- U.S. Renal Care and Akebia Announce Interim Analysis of
- U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA
- Vafseo trial stops early after safety win in dialysis patients
- U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA
- U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come U.S. Renal Care?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili